Per os; sc.: Subcutaneous injection; UC: Ulcerative colitis. Numerous biological agents are currently available for the treatment of patients with inflammatory bowel disease (IBD). These agents ...

New drug delivery technologies, such as nanoparticles, hydrogels, and self-powered microgrippers, are showing great potential ...

The topic of biologic therapy for IBD has been selected for this Focus issue of Nature Reviews Gastroenterology & Hepatology because of the important implications it has for disease management.

Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...

Table 1. Summary of biological therapies of inflammatory bowel disease. Target or supplement Agent name (nature) Application Usage Ref. Anti-TNF Infliximab (mAb) UC, CD, approved by US FDA iv.